The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...

German retail sales rose in 2024, but growth should be more modest this year due to the high level of uncertainty, according ...

We recently compiled a list of the Goldman Sachs’ 35 AI Superstars. In this article, we are going to take a look at where ...

Wall Street analysts forecast the company will manage a 4.3% revenue increase in 2025, accompanied by a 1.5% rebound in EPS.

Lockheed Martin has experienced a year of progress in 2024, with a sales increase of 5% and a year-end backlog valued at ...

Read about RTX's fourth-quarter financial performance, including 9 percent sales growth and $218 billion in total backlog.

Read about Lockheed Martin's financial results for 2024 and learn more about the business performances that contributed to it ...

Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...

Kimberly-Clark Corporation traded lower in premarket action on Tuesday after the household products company posted a mixed Q4 ...

Again the sticky point for Tesla's quarterly revenue was lower average selling price for its EVs, the company said. Despite being a miss relative to expectations, the $25.7 billion revenue was a 2% ...

The company projects mid to high single-digit sales growth in 2025 at constant exchange rates, excluding hyperinflation effects, and low double-digit business EPS growth before foreign exchange and ...